Skip to main content

Longitudinal Subtyping Of Atopic Dermatitis Through Skin Analysis

Research Question:
Is the type 2-high non-lesional skin (skin tape) type is associated with mild versus moderate-to-severe atopic dermatitis?

Basic Study Information

This is a study which will characterize the gene expression profiles that underlie mild and moderate-severe Atopic dermatitis (AD). It will determine changes in these expression patterns in response to standard-of-care treatment. Participants will complete up to ten study visits with assessment of topical steroid response and dupilumab response (if uncontrolled with topical steroids). Skin samples will be collected at all study visits to determine the gene expression profiles that underlie mild vs. moderate-severe atopic dermatitis. Healthy participants without atopic dermatitis will serve as a control population and must agree to apply a topical moisturizer (Vanicream) at least twice daily for 7 days. Atopic dermatitis patients must have chronic AD with active lesions.

Location: University of Rochester Medical Center: Department of Dermatology
Study Reference #: STUDY00007746

Lead Researcher (Principal Investigator)

Lead Researcher:  Lisa Beck

Study Contact Information

Study Coordinator: Michelle Smith
Phone: (585) 275-0374

Additional Study Details

Number of Visits:  6 to 10
Parking:  Free
Reimbursement:  Yes
Payment Details:  Study reimbursement also includes a $20 travel stipend per visit.

Learn More About These Conditions

More information about Dermatitis

More information about Dermatitis, Atopic

More information about Eczema

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search